A distributed infrastructure for life-science information
Supporting industry and stimulating innovation
ELIXIR supports open innovation, and promotes the adoption of widely adopted standards. This reduces barriers between information sharing and helps facilitate cross-company research partnerships. Industry is already a large user of public bioinformatics resources. For example, in 2012, the number of hits on the EMBL-EBI website from commercial IP addresses was 110 million. From drug discovery to sustainable manufacturing, industry increasingly relies on safe, secure access to bioinformatics datasets, tools, training and standards. In order to develop new products and services.
Understanding industry's needs
In 2013, Connected Discovery carried out an initial assessment of the needs of industry from ELIXIR. This exercise resulted in a series of recommendations being made, including:
Establishing an Industry Advisory Committee, including representatives of users, suppliers and publishers, to provide high-level strategic advice on ELIXIR's services
Roll out an Innovation and SME programme, which fosters the ELIXIR Nodes structure and provides a collaborative network for open services development
Create an industry dissemination channel to distribute information on industry-relevant news and events from ELIXIR Nodes
Development of an ELIXIR-cloud for SMEs
Many of these recommendations will be implemented through the ELIXIR Programme for 2014-2018.
Jérôme Wojcik, CEO of Quartz Bio, gave a talk on industry's needs from ELIXIR, which is available here.
Industry Advisory Committee
In order to receive high-level, strategic advice and input from industry, ELIXIR has establised an Industry Advisory Committee (IAC), made up of experts from users, including SMEs, suppliers and publishers. Following an open nomination process carried out during summer 2014.